Cargando…
Combined effect of early diagnosis and treatment on the case fatality risk of COVID-19 in Japan, 2020
Japanese government initially enforced restrictions on outpatient attendances among febrile individuals suspected of having COVID-19, asking everyone to remain at home for at least 4 days from the onset of fever. This restriction was cancelled on 8 May 2020, and a new antiviral, remdesivir, was appr...
Autores principales: | Amemiya, Yuri, Nishiura, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124700/ https://www.ncbi.nlm.nih.gov/pubmed/37095151 http://dx.doi.org/10.1038/s41598-023-33929-y |
Ejemplares similares
-
Estimating infection fatality risk and ascertainment bias of COVID-19 in Osaka, Japan from February 2020 to January 2022
por: Zhang, Tong, et al.
Publicado: (2023) -
A Comparison of Case Fatality Risk of COVID-19 between Singapore and Japan
por: Kayano, Taishi, et al.
Publicado: (2020) -
Time-dependent risk of COVID-19 death with overwhelmed health-care capacity in Japan, 2020–2022
por: Hayashi, Katsuma, et al.
Publicado: (2022) -
COVID-19 and Fatal Sepsis Caused by Hypervirulent Klebsiella pneumoniae, Japan, 2020
por: Hosoda, Tomohiro, et al.
Publicado: (2021) -
Real-Time Estimation of the Case Fatality Ratio and Risk Factors of Death
por: Nishiura, Hiroshi
Publicado: (2017)